| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Options Exercise | $0 | +3.46K | +2% | $0.00 | 176K | 12 Feb 2025 | Direct | F1 |
| transaction | BSX | Common Stock | Tax liability | -$167K | -1.58K | -0.9% | $105.77 | 175K | 12 Feb 2025 | Direct | |
| holding | BSX | Common Stock | 4.89K | 12 Feb 2025 | By Child | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Restricted Stock Units | Options Exercise | $0 | -3.46K | -25% | $0.00 | 10.4K | 12 Feb 2025 | Common Stock | 3.46K | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F2 | The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose. |
| F3 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. |